Collaboration as the key to turning around the drug discovery business (Part 2) – The Hypothesis

Read Part 1: Collaboration as the key to turning around the drug discovery business  – The Problem

The Hypothesis: Challenges facing individual researchers and drug discovery organizations could potentially be addressed en masse if collaborative processes and technologies were embraced to realize the economic benefits of well-integrated specialization. Collaborative capabilities (when well developed, implemented, & adopted), allow multiple individuals to combine various ideas and perspectives, as if they were all coherently contained in a single brain.  Collaborative capabilities (when well developed, implemented, & adopted) with secure data partitioning capabilities “in the cloud” allow multiple specialized organizations, to work naturally, as if one company.

Read Part 3: Collaboration as the key to turning around the drug discovery business  – A Solution

You can also download the full series “Collaboration as the key to turning around the drug discovery business” by Barry Bunin as a pdf document:


full-series